Literature DB >> 26773869

Carbonyl stress phenomena during chronic infection with Opisthorchis felineus.

Irina V Saltykova1, Ludmilla M Ogorodova2, Vladimir V Ivanov2, Aleksandr O Bogdanov2, Elena A Gereng2, Ekaterina A Perina2, Paul J Brindley3, Alexsey E Sazonov4.   

Abstract

Infection with the fish borne liver fluke Opisthorchis felineus is common in the Eastern Europe (Ukraine, European part of Russia), Northern Asia (Siberia) and Central Asia (Northern Kazakhstan). Better understanding of the molecular pathogenesis of the biliary tract and liver during chronic opisthorchiasis can be expected to improve protection against and management of complications of this disease. We hypothesize that infection with O. felineus associates with formation of methylglyoxal and carbonyl stress in the liver and hence here we investigated the glyoxalase system and the receptor for advanced glycated end products (RAGE) in the liver of hamsters infected with this liver fluke. Expression of mRNA encoding glyoxalase 1 decreased at 8weeks of the infection and catalytic activity as well decreased at 8 and 12weeks after infection, and the expression of the glyoxalase 2 decreased until 36week post-infection, which associated with the decreasing activity of the enzyme at 8 and 12weeks post-infection. Glutathione levels in infected livers had decreased at week 8, whereas up-regulation of RAGE at mRNA levels was seen for the extended duration of the experimental infection of the hamsters. This outcome supported the notion of hepatic dicarbonyl stress during chronic opisthorchiasis. The inhibition of the glyoxalase system and accumulation of methylglyoxal at the early stages of the infection may underpin development of insulin resistance during opisthorchiasis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Advanced glycation end products; Glutathione; Glycation; Glyoxalase 1; Glyoxalase 2; Opisthorchis felineus; RAGE

Mesh:

Substances:

Year:  2016        PMID: 26773869      PMCID: PMC4938777          DOI: 10.1016/j.parint.2016.01.002

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  34 in total

1.  Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.

Authors:  Giuseppina Basta; Guido Lazzerini; Marika Massaro; Tommaso Simoncini; Piero Tanganelli; Caifeng Fu; Thomas Kislinger; David M Stern; Ann Marie Schmidt; Raffaele De Caterina
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

2.  Gene expression. Statistics requantitates the central dogma.

Authors:  Jingyi Jessica Li; Mark D Biggin
Journal:  Science       Date:  2015-03-06       Impact factor: 47.728

3.  Comparative histopathology of Opisthorchis felineus and Opisthorchis viverrini in a hamster model: an implication of high pathogenicity of the European liver fluke.

Authors:  Maria N Lvova; Sirikachorn Tangkawattana; Suwit Balthaisong; Alexey V Katokhin; Viatcheslav A Mordvinov; Banchob Sripa
Journal:  Parasitol Int       Date:  2011-08-10       Impact factor: 2.230

4.  Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection.

Authors:  Nopparat Songserm; Jiraporn Prasongwattana; Paiboon Sithithaworn; Banchob Sripa; Vichit Pipitkool
Journal:  Asian Pac J Cancer Prev       Date:  2009 Apr-Jun

5.  Purification and characterization of two forms of glyoxalase II from the liver and brain of Wistar rats.

Authors:  G B Principato; G Rosi; V Talesa; E Giovannini; L Uotila
Journal:  Biochim Biophys Acta       Date:  1987-02-25

6.  Changes in expression and activity of glutathione S-transferase in different organs of schistosoma haematobium-infected hamster.

Authors:  S A Sheweita; M H Mostafa; F Ebid; W El-Sayed
Journal:  J Biochem Mol Toxicol       Date:  2003       Impact factor: 3.642

Review 7.  Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors.

Authors:  P J Thornalley
Journal:  Chem Biol Interact       Date:  1998-04-24       Impact factor: 5.192

8.  Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells.

Authors:  Bei-Bing Di; Hong-Wei Li; Wei-Ping Li; Xu-Hua Shen; Zhi-Jun Sun; Xing Wu
Journal:  Mol Med Rep       Date:  2014-12-18       Impact factor: 2.952

9.  The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity.

Authors:  Matthias Oelze; Swenja Kröller-Schön; Philipp Welschof; Thomas Jansen; Michael Hausding; Yuliya Mikhed; Paul Stamm; Michael Mader; Elena Zinßius; Saule Agdauletova; Anna Gottschlich; Sebastian Steven; Eberhard Schulz; Serge P Bottari; Eric Mayoux; Thomas Münzel; Andreas Daiber
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

10.  Low genetic diversity in wide-spread Eurasian liver fluke Opisthorchis felineus suggests special demographic history of this trematode species.

Authors:  Ilja I Brusentsov; Alexey V Katokhin; Irina V Brusentsova; Sergei V Shekhovtsov; Sergei N Borovikov; Grigoriy G Goncharenko; Lyudmila A Lider; Boris V Romashov; Olga T Rusinek; Samat K Shibitov; Marat M Suleymanov; Andrey V Yevtushenko; Viatcheslav A Mordvinov
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

View more
  2 in total

1.  Co-occurrence of opisthorchiasis and diabetes exacerbates morbidity of the hepatobiliary tract disease.

Authors:  Apisit Chaidee; Sudarat Onsurathum; Kitti Intuyod; Patchareewan Pannangpetch; Chatlert Pongchaiyakul; Porntip Pinlaor; Chawalit Pairojkul; Wannaporn Ittiprasert; Christina J Cochran; Victoria H Mann; Paul J Brindley; Somchai Pinlaor
Journal:  PLoS Negl Trop Dis       Date:  2018-06-28

Review 2.  Parasite Infection, Carcinogenesis and Human Malignancy.

Authors:  Hoang van Tong; Paul J Brindley; Christian G Meyer; Thirumalaisamy P Velavan
Journal:  EBioMedicine       Date:  2016-12-02       Impact factor: 8.143

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.